SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-14-001953
Filing Date
2014-12-01
Accepted
2014-12-01 06:30:10
Documents
5
Period of Report
2014-12-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 THERAVANCE 8K theravance8k.htm 8-K 31443
2 EXHIBIT 99.1 anoroellipta.htm EX-99.1 41891
3 EXHIBIT 99.2 breoellipta.htm EX-99.2 50794
4 GSK LOGO gsk.jpg GRAPHIC 5544
5 THERAVANCE LOGO theravance.jpg GRAPHIC 5079
  Complete submission text file 0001102624-14-001953.txt   140199
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 141256345
SIC: 2834 Pharmaceutical Preparations